LYMPHOMA TRANSFORMATION

This adverse event was reported 360 times

LYMPHOMA TRANSFORMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZANUBRUTINIB 24 0.0053
1 ETOPOSIDE PHOSPHATE 7 0.0043
2 BENDAMUSTINE HYDROCHLORIDE 36 0.0042
3 IBRITUMOMAB TIUXETAN 6 0.0039
4 POLATUZUMAB VEDOTIN 40 0.0039
5 AVELUMAB 15 0.0037
6 SUTIMLIMAB-JOME 1 0.0031
7 IDELALISIB 19 0.0027
8 BENDAMUSTINE HCL 38 0.0024
9 OBINUTUZUMAB 40 0.0024
See all drugs enriched for association with LYMPHOMA TRANSFORMATION